Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of maralixibat in pediatric Alagille syndrome
2013-003832-54Phase 2Completed
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of maralixibat in Alagille syndrome (ALGS), sponsored by Mirum Pharmaceuticals, Inc. Started Dec 2013; status: completed.
02
Drugs
maralixibat
03
Conditions
Alagille syndrome (ALGS)
Beyond the preview
Go deeper on 2013-003832-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003832-54.